P3 Health Partners Inc. has 1 Schedule 13D or 13G filing on record since 2026-08-12. 1 holder's latest filing reports 5% or more of class a common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Hudson Vegas Investment SPV, LLC | 17.5% | 829,651 | SCHEDULE 13D/A, 2026-08-12 | 2026-08-10 |
Purpose of Transaction (Item 4)
Hudson Vegas Investment SPV, LLC
Item 4 of the Original Schedule 13D is amended and supplemented as follows: On August 22, 2024, the Delaware Action was dismissed by the parties without the admission of fault or liability. None of the shares of Class V Common Stock or P3 LLC Units listed in this Amendment as beneficially owned by any of the Reporting Person are held in escrow subject to the Escrow Agreement. On June 10, 2026, Hudson Vegas Investment SPV, LLC exercised its right to cause P3 to redeem an aggregate 50,000 P3 LLC Units held by Hudson Vegas Investment SPV, LLC for an equal number of shares of Class A Common Stock in accordance with the terms of the P3 LLC A&R LLC Agreement. An aggregate of 50,000 shares of Class V Common Stock held by Hudson Vegas Investment SPV, LLC were cancelled in connection with such redemption. On August 10, 2026, Hudson Vegas Investment SPV, LLC sold (i) an aggregate of 1,041 shares of Class A Common Stock at a weighted average price per share of $13.38 in multiple transactions at prices ranging from $13.00 to $13.61, (ii) an aggregate of 19,074 shares of Class A Common Stock at a weighted average price per share of $16.05 in multiple transactions at prices ranging from $16.00 to $16.24 and (iii) an aggregate of 29,885 shares of Class A Common Stock at a weighted average price per share of $16.86 in multiple transactions at prices ranging from $16.25 to $17.24. All such sales were effected in the open market through brokers and the price per share excludes commissions. …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-08-12; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-08-12 | Hudson Vegas Investment SPV, LLC | 17.5% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for P3 Health Partners Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.